Completed PHASE2 INTERVENTIONAL 3-arm NCT02316717

A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis

A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.

Sponsor: Immuron Ltd.

Conditions Non-alcoholic Steatohepatitis (NASH)

Interventions IMM-124E Placebo

Updated 8 times since 2017 Last updated: Feb 8, 2020 Started: Dec 31, 2014 Primary completion: Oct 30, 2017 Completion: Oct 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Non-alcoholic Steatohepatitis (NASH) and is currently completed. Immuron Ltd. leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Mar 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Mar 2020 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — Dec 2017 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Immuron Ltd.

Data source: Immuron Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States , Box Hill, Australia , Charlottesville, United States , Chicago, United States , Chula Vista, United States , Cleveland, United States , Durham, United States , Gainesville, United States , Houston, United States , Jerusalem, Israel and 13 more locations